{"success":true,"data":{"pressRelease":{"id":"156899","rtpr_id":"nACSSJ5Bga-20260930","ticker":"MDT","exchange":"NYSE","all_tickers":["MDT"],"title":"Medtronic Named to Fortune 2026 'Change the World' List for Touch Surgery(TM) Ecosystem and Healthy Neighbor","author":"ACCESSWIRE","published_at":"2026-09-30T13:25:00.155Z","article_body":"NORTHAMPTON, MA / ACCESS Newswire (https://www.accessnewswire.com/) /\nSeptember 30, 2026 / Medtronic today announced it has been named to the\nprestigious FORTUNE 2026 ‘Change the World' list (https://pr.report/qx3m)\nfor its Touch Surgery™ ecosystem and Healthy Neighbor program through\nMedtronic LABS. The annual list showcases companies working to combat global\nissues and drive positive social or environmental change.\n\nThe recognition highlights how Medtronic is harnessing technology to improve\nhealthcare outcomes from the operating room to underserved communities.\n\nTouch Surgery™ ecosystem transforms the future of surgery\nThe Touch Surgery (TM) ecosystem uses AI to analyze surgery and enables\nlivestreaming for remote collaboration, helping physicians review procedures\nand improve surgical practices. Connecting the full surgical journey from\nplanning and training to intraoperative collaboration, Touch Surgery now\nsupports thousands of surgeons in 30+ countries worldwide. Announced in July\n2026, Touch Surgery(TM) Aide, the next-generation compute platform for the\noperating rooms, extends the platform by adding AI-powered, real-time support.\nThis helps surgeons access actionable insights during robotic and laparoscopic\nprocedures while enabling teams to review cases and continuously improve\nsurgical decision-making.\n\n\"Our vision is to make the best surgery available to more people, regardless\nof where they live,\" said Matt Anderson, senior vice president and president,\nSurgical business at Medtronic. \"The Touch Surgery (TM) ecosystem enables\nsurgeons to deliver upon intelligence and perform procedures with greater\nconsistency and confidence, helping to advance Medtronic's commitment to\nexpand access to the best possible care around the world.\"\n\nMedtronic LABS addresses health disparities with Virtua Health\nIn partnership with Virtua Health, the Healthy Neighbor program\n(https://pr.report/qx3n) was designed to address chronic health disparities in\nCamden, New Jersey. Located just across the river from Philadelphia, Camden\nresidents face a reduction in life expectancy of nearly 16 years compared to\nneighborhoods just 6.5 miles away (https://pr.report/qx3o). In particular, the\nrates of diabetes and high blood pressure in Camden are dramatically higher\nthan in nearby communities.\n\nVirtua Health partnered with Medtronic LABS, a nonprofit funded by Medtronic,\nto bring community health workers directly to the homes of those with high\nblood pressure and/or type 2 diabetes for ongoing healthcare coordination.\nEach team member is equipped with a digital health platform, streamlining\ntheir work by capturing basic healthcare information, tracking blood pressure\nand glucose over time, and flagging elevated readings for follow-up. After two\nyears, results from more than 250 patients enrolled showed:\n* 74% of patients with uncontrolled hypertension achieved meaningful\nimprovement, with an average 15-point drop in systolic blood pressure.\n* 69% of patients with uncontrolled diabetes achieved a meaningful improvement\nwith a 1.2% mean drop in A1C.\n* These improvements in blood pressure and hemoglobin A1C control are linked\nto a significant reduction in debilitating long-term complications.(1)\n\"Being recognized is not just an honor, but an affirmation that our work at\nMedtronic to put patients first in every aspect of the business is making a\nmeaningful impact,\" said Ruchika Singhal, president of Medtronic LABS. \"True\ninnovation in healthcare should be comprehensive - from developing the\ntechnology itself to rethinking delivery models - and should improve health\noutcomes no matter your ZIP code or income.\"\n\nAbout Medtronic\nBold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered\nin Galway, Ireland, is the leading global healthcare technology company that\nboldly attacks the most challenging health problems facing humanity by\nsearching out and finding solutions. Our Mission - to alleviate pain, restore\nhealth, and extend life - unites a global team of 95,000+ passionate people\nacross more than 150 countries. Our technologies and therapies treat 70 health\nconditions and include cardiac devices, surgical robotics, insulin pumps,\nsurgical tools, patient monitoring systems, and more. Powered by our diverse\nknowledge, insatiable curiosity, and desire to help all those who need it, we\ndeliver innovative technologies that transform the lives of two people every\nsecond, every hour, every day. Expect more from us as we empower\ninsight-driven care, experiences that put people first, and better outcomes\nfor our world. In everything we do, we are engineering the extraordinary. For\nmore information on Medtronic, visit www.Medtronic.com and follow on LinkedIn\n(https://pr.report/qx3q).\n\nAbout Medtronic LABS\n\nMedtronic LABS is a non-profit organization that develops community-based,\ntech-enabled solutions for underserved patients, families, and communities\nacross the world. By bridging hyper-local services with cutting-edge\ntechnology, we provide sustainable and localized healthcare solutions that\nproduce measurable outcomes for all. We have served patients through eight\nprograms across sub-Saharan Africa, South Asia, and the United States. To\ndate, we have screened nearly 2M individuals for chronic diseases, enrolled\n414,000 in our management programs, and achieved measurable improvements in\nhealth and wellbeing for 219,000 patients.\n\nwww.medtroniclabs.org\n\nAny forward-looking statements are subject to risks and uncertainties such as\nthose described in Medtronic's periodic reports on file with the Securities\nand Exchange Commission. Actual results may differ materially from anticipated\nresults.\n\n(1)Uncontrolled hypertension is defined as a baseline reading ≥140/90\n(n=58). Uncontrolled diabetes is defined as baseline HbA1c ≥ 8% (n=26).\nMeaningful improvement in blood pressure is defined as achieving blood\npressure control (<140/90) or a ≥10mmHg reduction in systolic blood\npressure. Meaningful improvement in HbA1c is defined as achieving control\n(HbA1c <8%) or ≥1% reduction in HbA1c.\n\n(https://app.accessnewswire.com/imagelibrary/6dbd2292-87fe-4014-8eb7-77c61c45319b/1228984/ea7e5049-775b-4370-b1db-38ec7276dc34.jpg)\n\nFind more stories and multimedia from Medtronic at 3blmedia.com.\n(https://pr.report/qx3s)\n\nContact Info:\nSpokesperson: Medtronic\nWebsite: https://www.3blmedia.com/profiles/medtronic\nEmail: info@3blmedia.com\n\nSOURCE: Medtronic\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/medtronic-named-to-fortune-2026-change-the-world-list-for-touch-surge-1228984)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nACSSJ5Bga-20260930","title":"Medtronic Named to Fortune 2026 'Change the World' List for Touch Surgery(TM) Ecosystem and Healthy Neighbor","author":"ACCESSWIRE","ticker":"MDT","created":"2026-09-30T13:25:00.155Z","tickers":["MDT"],"exchange":"NYSE","article_body":"NORTHAMPTON, MA / ACCESS Newswire (https://www.accessnewswire.com/) /\nSeptember 30, 2026 / Medtronic today announced it has been named to the\nprestigious FORTUNE 2026 ‘Change the World' list (https://pr.report/qx3m)\nfor its Touch Surgery™ ecosystem and Healthy Neighbor program through\nMedtronic LABS. The annual list showcases companies working to combat global\nissues and drive positive social or environmental change.\n\nThe recognition highlights how Medtronic is harnessing technology to improve\nhealthcare outcomes from the operating room to underserved communities.\n\nTouch Surgery™ ecosystem transforms the future of surgery\nThe Touch Surgery (TM) ecosystem uses AI to analyze surgery and enables\nlivestreaming for remote collaboration, helping physicians review procedures\nand improve surgical practices. Connecting the full surgical journey from\nplanning and training to intraoperative collaboration, Touch Surgery now\nsupports thousands of surgeons in 30+ countries worldwide. Announced in July\n2026, Touch Surgery(TM) Aide, the next-generation compute platform for the\noperating rooms, extends the platform by adding AI-powered, real-time support.\nThis helps surgeons access actionable insights during robotic and laparoscopic\nprocedures while enabling teams to review cases and continuously improve\nsurgical decision-making.\n\n\"Our vision is to make the best surgery available to more people, regardless\nof where they live,\" said Matt Anderson, senior vice president and president,\nSurgical business at Medtronic. \"The Touch Surgery (TM) ecosystem enables\nsurgeons to deliver upon intelligence and perform procedures with greater\nconsistency and confidence, helping to advance Medtronic's commitment to\nexpand access to the best possible care around the world.\"\n\nMedtronic LABS addresses health disparities with Virtua Health\nIn partnership with Virtua Health, the Healthy Neighbor program\n(https://pr.report/qx3n) was designed to address chronic health disparities in\nCamden, New Jersey. Located just across the river from Philadelphia, Camden\nresidents face a reduction in life expectancy of nearly 16 years compared to\nneighborhoods just 6.5 miles away (https://pr.report/qx3o). In particular, the\nrates of diabetes and high blood pressure in Camden are dramatically higher\nthan in nearby communities.\n\nVirtua Health partnered with Medtronic LABS, a nonprofit funded by Medtronic,\nto bring community health workers directly to the homes of those with high\nblood pressure and/or type 2 diabetes for ongoing healthcare coordination.\nEach team member is equipped with a digital health platform, streamlining\ntheir work by capturing basic healthcare information, tracking blood pressure\nand glucose over time, and flagging elevated readings for follow-up. After two\nyears, results from more than 250 patients enrolled showed:\n* 74% of patients with uncontrolled hypertension achieved meaningful\nimprovement, with an average 15-point drop in systolic blood pressure.\n* 69% of patients with uncontrolled diabetes achieved a meaningful improvement\nwith a 1.2% mean drop in A1C.\n* These improvements in blood pressure and hemoglobin A1C control are linked\nto a significant reduction in debilitating long-term complications.(1)\n\"Being recognized is not just an honor, but an affirmation that our work at\nMedtronic to put patients first in every aspect of the business is making a\nmeaningful impact,\" said Ruchika Singhal, president of Medtronic LABS. \"True\ninnovation in healthcare should be comprehensive - from developing the\ntechnology itself to rethinking delivery models - and should improve health\noutcomes no matter your ZIP code or income.\"\n\nAbout Medtronic\nBold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered\nin Galway, Ireland, is the leading global healthcare technology company that\nboldly attacks the most challenging health problems facing humanity by\nsearching out and finding solutions. Our Mission - to alleviate pain, restore\nhealth, and extend life - unites a global team of 95,000+ passionate people\nacross more than 150 countries. Our technologies and therapies treat 70 health\nconditions and include cardiac devices, surgical robotics, insulin pumps,\nsurgical tools, patient monitoring systems, and more. Powered by our diverse\nknowledge, insatiable curiosity, and desire to help all those who need it, we\ndeliver innovative technologies that transform the lives of two people every\nsecond, every hour, every day. Expect more from us as we empower\ninsight-driven care, experiences that put people first, and better outcomes\nfor our world. In everything we do, we are engineering the extraordinary. For\nmore information on Medtronic, visit www.Medtronic.com and follow on LinkedIn\n(https://pr.report/qx3q).\n\nAbout Medtronic LABS\n\nMedtronic LABS is a non-profit organization that develops community-based,\ntech-enabled solutions for underserved patients, families, and communities\nacross the world. By bridging hyper-local services with cutting-edge\ntechnology, we provide sustainable and localized healthcare solutions that\nproduce measurable outcomes for all. We have served patients through eight\nprograms across sub-Saharan Africa, South Asia, and the United States. To\ndate, we have screened nearly 2M individuals for chronic diseases, enrolled\n414,000 in our management programs, and achieved measurable improvements in\nhealth and wellbeing for 219,000 patients.\n\nwww.medtroniclabs.org\n\nAny forward-looking statements are subject to risks and uncertainties such as\nthose described in Medtronic's periodic reports on file with the Securities\nand Exchange Commission. Actual results may differ materially from anticipated\nresults.\n\n(1)Uncontrolled hypertension is defined as a baseline reading ≥140/90\n(n=58). Uncontrolled diabetes is defined as baseline HbA1c ≥ 8% (n=26).\nMeaningful improvement in blood pressure is defined as achieving blood\npressure control (<140/90) or a ≥10mmHg reduction in systolic blood\npressure. Meaningful improvement in HbA1c is defined as achieving control\n(HbA1c <8%) or ≥1% reduction in HbA1c.\n\n(https://app.accessnewswire.com/imagelibrary/6dbd2292-87fe-4014-8eb7-77c61c45319b/1228984/ea7e5049-775b-4370-b1db-38ec7276dc34.jpg)\n\nFind more stories and multimedia from Medtronic at 3blmedia.com.\n(https://pr.report/qx3s)\n\nContact Info:\nSpokesperson: Medtronic\nWebsite: https://www.3blmedia.com/profiles/medtronic\nEmail: info@3blmedia.com\n\nSOURCE: Medtronic\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/medtronic-named-to-fortune-2026-change-the-world-list-for-touch-surge-1228984)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved."},"type":"article","timestamp":"2026-09-30T13:25:00.203082693Z","server_sent_at_ms":1790774700203},"received_at":"2026-09-30T13:25:00.259Z","source_url":"https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/medtronic-named-to-fortune-2026-change-the-world-list-for-touch-surge-1228984"},"analysis":{"id":"145576","press_release_id":"156899","analysis_json":{"industry":{"label":"Health Care Equipment & Supplies","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"Medtronic was named to the FORTUNE 2026 'Change the World' list for its Touch Surgery ecosystem and the Healthy Neighbor program run through Medtronic LABS.\n\nTouch Surgery now supports thousands of surgeons in 30+ countries, and the July 2026 launch of Touch Surgery Aide added AI-powered real-time support for robotic and laparoscopic procedures.\n\nThe Healthy Neighbor program with Virtua Health in Camden, NJ reported that 74% of patients with uncontrolled hypertension and 69% with uncontrolled diabetes achieved meaningful improvement over two years.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"ESG/recognition release -- no earnings or guidance impact; suppress unless tracking Medtronic surgical AI narrative."},"keyFigures":{"customDimensions":{"diabetes_a1c_drop":"1.2% mean","surgeon_countries":"30+","diabetes_improvement":"69%","hypertension_improvement":"74%","hypertension_systolic_drop":"15-point average","healthy_neighbor_patients_enrolled":"more than 250"}},"quotedText":"Our vision is to make the best surgery available to more people, regardless of where they live","namedEntities":{"people":[{"name":"Matt Anderson","role":"SVP and president, Surgical business at Medtronic"},{"name":"Ruchika Singhal","role":"president of Medtronic LABS"}],"products":["Touch Surgery ecosystem","Touch Surgery Aide"],"companies":[{"name":"Medtronic plc","ticker":"MDT","relationship":"filer"},{"name":"Medtronic LABS","relationship":"nonprofit funded by Medtronic"},{"name":"Virtua Health","relationship":"partner"},{"name":"Fortune","relationship":"publisher of Change the World list"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Corporate-recognition/ESG-style press release with no financial, regulatory, or operational impact on results. Touch Surgery metrics are marketing scale figures, not new disclosures."},"tickerRelevance":{"others":[],"primary":"MDT"},"globalImportance":8,"audienceRelevance":10,"eventTypeSecondary":["operations_update"],"importanceComponents":{"tickerTier":"mega-cap","eventGravity":"corporate-recognition/ESG","issuerAuthored":true}},"event_type":"other","event_type_secondary":["operations_update"],"sentiment":"neutral","material_impact_score":1,"narrative":"Medtronic was named to the FORTUNE 2026 'Change the World' list for its Touch Surgery ecosystem and the Healthy Neighbor program run through Medtronic LABS.\n\nTouch Surgery now supports thousands of surgeons in 30+ countries, and the July 2026 launch of Touch Surgery Aide added AI-powered real-time support for robotic and laparoscopic procedures.\n\nThe Healthy Neighbor program with Virtua Health in Camden, NJ reported that 74% of patients with uncontrolled hypertension and 69% with uncontrolled diabetes achieved meaningful improvement over two years.","key_figures":{"customDimensions":{"diabetes_a1c_drop":"1.2% mean","surgeon_countries":"30+","diabetes_improvement":"69%","hypertension_improvement":"74%","hypertension_systolic_drop":"15-point average","healthy_neighbor_patients_enrolled":"more than 250"}},"named_entities":{"people":[{"name":"Matt Anderson","role":"SVP and president, Surgical business at Medtronic"},{"name":"Ruchika Singhal","role":"president of Medtronic LABS"}],"products":["Touch Surgery ecosystem","Touch Surgery Aide"],"companies":[{"name":"Medtronic plc","ticker":"MDT","relationship":"filer"},{"name":"Medtronic LABS","relationship":"nonprofit funded by Medtronic"},{"name":"Virtua Health","relationship":"partner"},{"name":"Fortune","relationship":"publisher of Change the World list"}],"dollarAmounts":[]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-30T13:25:05.509Z","global_importance":8,"audience_relevance":10,"importance_components":{"tickerTier":"mega-cap","eventGravity":"corporate-recognition/ESG","issuerAuthored":true}},"durationMs":5224,"modelName":"glm-5.3-flashx"}}